Login
|
Register
|
中文
|
Home
Company
Catalog
Order
Support
Contact
About
About
RiboBio News
Industry News
RNAi
Your present position：Focus on RNAi > RNAi
MiRNA-95在促进结肠癌细胞增殖中的调控作用
CDK1抑制性磷酸化在有丝分裂结束机制中的补偿性作用
PloS ONE: MiRNA-29a在肝癌细胞转移中的调控作用
JBC：miRNA簇提高诱导干细胞（IPS）诱导效率
SurModics与Egen将共同开发稳定性siRNA
Dicerna Pharma投资以开发新一代基因沉默药物
Simulations Plus Reports $3M in Preliminary Q3 Rev
The siRNA targeted to mdr1b and mdr1a mRNAs in viv
Tekmira Partner Alnylam Presents ALN-VSP Preliminary Phase 1 Clinical Trial...
Santaris Plans Phase II Trial of miRNA-Targeting HCV Drug
Alnylam Biotherapeutics Presents New Results on Use of RNAi Technologies fo...
MDRNA, Inc. Announces Combinations of UsiRNAs in Proprietary DiLA2 Delivery...
Scientists Trigger Antitumor Immune Responses Using siRNAs
TransDerm Inks Research Deal with RXi, Gets Grant to Explore Delivery Techn...
Targeting Tau in Alzheimer's
Total
354
Records Total
24
Page Current Page
1
Page
First
upPage
NextPage
End
Jump to
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Copyright :2004-2009, Guangzhou RiboBio Co., Ltd.
Guangzhou International Business Incubator D906, Guangzhou Science Park, Guangzhou, China Post:510663
